메뉴 건너뛰기




Volumn 29, Issue 48, 2011, Pages 9104-9111

The cost-effectiveness of rotavirus vaccination in Armenia

Author keywords

Armenia; Cost effectiveness; Rotavirus; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

EID: 82455192273     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.127     Document Type: Article
Times cited : (18)

References (38)
  • 3
    • 36248995945 scopus 로고    scopus 로고
    • Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
    • Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370(November (9601)):1757-1763.
    • (2007) Lancet , vol.370 , pp. 1757-1763
    • Vesikari, T.1    Karvonen, A.2    Prymula, R.3    Schuster, V.4    Tejedor, J.C.5    Cohen, R.6
  • 4
    • 30044442208 scopus 로고    scopus 로고
    • Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
    • Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
    • (2006) N Engl J Med , vol.354 , pp. 23-33
    • Vesikari, T.1    Matson, D.O.2    Dennehy, P.3    Van Damme, P.4    Santosham, M.5    Rodriguez, Z.6
  • 5
    • 34547727758 scopus 로고    scopus 로고
    • WHO position paper
    • Rotavirus vaccines
    • Rotavirus vaccines WHO position paper. Wkly Epidemiol Rec 2007, 82(August (32)):285-295.
    • (2007) Wkly Epidemiol Rec , vol.82 , pp. 285-295
  • 6
    • 75549084597 scopus 로고    scopus 로고
    • Rotavirus vaccines: an update
    • Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009, 84(December (51-52)):533-537.
    • (2009) Wkly Epidemiol Rec , vol.84 , pp. 533-537
  • 7
    • 70349786426 scopus 로고    scopus 로고
    • The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe
    • Jit M., Bilcke J., Mangen M.J., Salo H., Melliez H., Edmunds W.J., et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine 2009, 27(October (44)):6121-6128.
    • (2009) Vaccine , vol.27 , pp. 6121-6128
    • Jit, M.1    Bilcke, J.2    Mangen, M.J.3    Salo, H.4    Melliez, H.5    Edmunds, W.J.6
  • 8
    • 77958192364 scopus 로고    scopus 로고
    • An update to " the cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe"
    • Jit M., Mangen M.J., Melliez H., Yazdanpanah Y., Bilcke J., Salo H., et al. An update to " the cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe" Vaccine 2010, 28(November (47)):7457-7459.
    • (2010) Vaccine , vol.28 , pp. 7457-7459
    • Jit, M.1    Mangen, M.J.2    Melliez, H.3    Yazdanpanah, Y.4    Bilcke, J.5    Salo, H.6
  • 14
    • 77249123257 scopus 로고    scopus 로고
    • Available from: [accessed on 10.10.10]
    • World Health Organization World health statistics 2008, Available from: http://www.who.int/whosis/whostat/2008/en/index.html [accessed on 10.10.10].
    • (2008) World Health Organization World health statistics
  • 15
    • 41449114965 scopus 로고    scopus 로고
    • Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study
    • Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371(April (9619)):1181-1189.
    • (2008) Lancet , vol.371 , pp. 1181-1189
    • Linhares, A.C.1    Velazquez, F.R.2    Perez-Schael, I.3    Saez-Llorens, X.4    Abate, H.5    Espinoza, F.6
  • 16
    • 77954100931 scopus 로고    scopus 로고
    • Health and economic impact of rotavirus vaccination in GAVI-eligible countries
    • Kim S.Y., Sweet S., Slichter D., Goldie S.J. Health and economic impact of rotavirus vaccination in GAVI-eligible countries. BMC Pub Health 2010, 10:253.
    • (2010) BMC Pub Health , vol.10 , pp. 253
    • Kim, S.Y.1    Sweet, S.2    Slichter, D.3    Goldie, S.J.4
  • 17
    • 84857901836 scopus 로고    scopus 로고
    • Available at:[accessed on 1.11.10], National Statistical Service of the Republic of Armenia
    • National Statistical Service of the Republic of Armenia Demographic handbook of Armenia 2009, Available at: http://www.armstat.am/file/article/demos_09_2.pdf [accessed on 1.11.10].
    • (2009) Demographic handbook of Armenia
  • 18
    • 65549116428 scopus 로고    scopus 로고
    • Estimated mortality and hospital admission due to rotavirus infection in the WHO European region
    • Williams C.J., Lobanov A., Pebody R.G. Estimated mortality and hospital admission due to rotavirus infection in the WHO European region. Epidemiol Infect 2009, 137(May (5)):607-616.
    • (2009) Epidemiol Infect , vol.137 , pp. 607-616
    • Williams, C.J.1    Lobanov, A.2    Pebody, R.G.3
  • 19
    • 84857909059 scopus 로고    scopus 로고
    • Available from: [accessed on 1.11.10], World Bank
    • World Bank Mortality rate, under-5 (per 1,000) 2010, Available from: http://data.worldbank.org/indicator/SH.DYN.MORT/countries/AM-7E-XN [accessed on 1.11.10].
    • (2010) Mortality rate, under-5 (per 1,000)
  • 21
    • 67649488093 scopus 로고    scopus 로고
    • Estimating the incidence of symptomatic rotavirus infections: a systematic review with meta-analysis
    • Bilcke J., Van Damme P., Van Ranst M., Hens N., Aerts M., Beutels P. Estimating the incidence of symptomatic rotavirus infections: a systematic review with meta-analysis. PLoS One 2009, 4(June (6)):e6060.
    • (2009) PLoS One , vol.4
    • Bilcke, J.1    Van Damme, P.2    Van Ranst, M.3    Hens, N.4    Aerts, M.5    Beutels, P.6
  • 22
    • 51049089556 scopus 로고    scopus 로고
    • Armenia 2005: results from the Demographic and Health Survey
    • Armenia 2005: results from the Demographic and Health Survey. Stud Fam Plann 2008, 39(September (3)):221-226.
    • (2008) Stud Fam Plann , vol.39 , pp. 221-226
  • 26
    • 80052101736 scopus 로고    scopus 로고
    • Available at: [accessed on 1.11.10], National Statistical Service of the Republic of Armenia
    • National Statistical Service of the Republic of Armenia Statistical yearbook of Armenia 2009, Available at: http://www.armstat.am/file/doc/99458068.pdf [accessed on 1.11.10].
    • (2009) Statistical yearbook of Armenia
  • 27
    • 84857895685 scopus 로고    scopus 로고
    • Available at: [accessed on 1.11.10], National Statistical Service of the Republic of Armenia
    • National Statistical Service of the Republic of Armenia Marzes of the republic of Armenia and Yerevan city in figures 2010, Available at: http://www.armstat.am/file/article/marz_10_22.pdf [accessed on 1.11.10].
    • (2010) Marzes of the republic of Armenia and Yerevan city in figures
  • 28
    • 59549085888 scopus 로고    scopus 로고
    • Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and " no medical care" disease impact in Belgium
    • Bilcke J., Van Damme P., Beutels P. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and " no medical care" disease impact in Belgium. Med Decis Making 2009, (January-Februrary (1)):33-50.
    • (2009) Med Decis Making , pp. 33-50
    • Bilcke, J.1    Van Damme, P.2    Beutels, P.3
  • 31
    • 80053422642 scopus 로고    scopus 로고
    • [accessed on 15.07.11], GAVI alliance
    • GAVI alliance GAVI welcomes lower prices for life-saving vaccines 2011, http://www.gavialliance.org/media_centre/press_releases/vaccine_prices.php [accessed on 15.07.11].
    • (2011) GAVI welcomes lower prices for life-saving vaccines
  • 32
    • 72849146973 scopus 로고    scopus 로고
    • Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries
    • Atherly D., Dreibelbis R., Parashar U.D., Levin C., Wecker J., Rheingans R.D. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis 2009, 200(November (Suppl. 1)):S28-S38.
    • (2009) J Infect Dis , vol.200 , Issue.SUPPL. 1
    • Atherly, D.1    Dreibelbis, R.2    Parashar, U.D.3    Levin, C.4    Wecker, J.5    Rheingans, R.D.6
  • 34
    • 77955345953 scopus 로고    scopus 로고
    • The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines
    • Knies S., Severens J.L., Ament A.J., Evers S.M. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines. Value Health 2010, 13(August (5)):519-527.
    • (2010) Value Health , vol.13 , pp. 519-527
    • Knies, S.1    Severens, J.L.2    Ament, A.J.3    Evers, S.M.4
  • 35
    • 47149105449 scopus 로고    scopus 로고
    • Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
    • Goldie S.J., O'Shea M., Campos N.G., Diaz M., Sweet S., Kim S.Y. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 2008, 26(July (32)):4080-4093.
    • (2008) Vaccine , vol.26 , pp. 4080-4093
    • Goldie, S.J.1    O'Shea, M.2    Campos, N.G.3    Diaz, M.4    Sweet, S.5    Kim, S.Y.6
  • 36
    • 33846630415 scopus 로고    scopus 로고
    • Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis
    • Sinha A., Levine O., Knoll M.D., Muhib F., Lieu T.A. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet 2007, 369(February (9559)):389-396.
    • (2007) Lancet , vol.369 , pp. 389-396
    • Sinha, A.1    Levine, O.2    Knoll, M.D.3    Muhib, F.4    Lieu, T.A.5
  • 38
    • 78650238955 scopus 로고    scopus 로고
    • Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan
    • de Blasio B.F., Kasymbekova K., Flem E. Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan. Vaccine 2010, 28(November (50)):7923-7932.
    • (2010) Vaccine , vol.28 , pp. 7923-7932
    • de Blasio, B.F.1    Kasymbekova, K.2    Flem, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.